首页 | 本学科首页   官方微博 | 高级检索  
     

蝮蛇抗栓酶治疗肺心病急性发作32例疗效观察
引用本文:蔡远玲,张乃芬. 蝮蛇抗栓酶治疗肺心病急性发作32例疗效观察[J]. 大理医学院学报, 2000, 9(1): 39-40
作者姓名:蔡远玲  张乃芬
作者单位:大理医学院玉溪教学医院呼吸内科
摘    要:目的:探讨蝮蛇抗栓酶在治疗肺心病急性发作中的临床应用价值。方法:采用蝮蛇抗栓酶联合其它综合措施治疗肺心病急性发作32例。结果:蝮蛇抗栓酶组32例显效20例,有效9例,总有效率达90.6%,对照组总有效率仅达65.6%。蝮蛇抗栓酶组疗效明显高于对照组(P〈0.05)。结论:蝮蛇抗栓酶的应用为治疗肺心病提供了有效的方法。

关 键 词:蝮蛇抗栓酶 肺心病 治疗
文章编号:1004-4442(2000)01-0039-02
修稿时间:1999-07-22

Therapeutic Effect of Ahylysantinfarctase on 32Cases with the Acute Episode of Chronic Cor pulmonale
Cai Yuanlin,Zhang Naifen , Zhou Hongjian. Therapeutic Effect of Ahylysantinfarctase on 32Cases with the Acute Episode of Chronic Cor pulmonale[J]. Journal of Dali Medical College, 2000, 9(1): 39-40
Authors:Cai Yuanlin  Zhang Naifen & Zhou Hongjian
Abstract:Objective: To study the therapeutic effect of Ahylysantinfarctase on acute episode of chronic cor pulmonale. Method: Using Ahylysantinfarctase with other therapeutic measures to treat 32 cases with acute episode of chronic cor pulmonale. Results: Of 32 cases treated by Ahylysantinfarctase, 20 cases show a prominent effect and 9 cases are better than before. The total effective rate reaches 90.6% in the test group (the group treated by Ahylysantinfarctase) while only 65.6% in the control group. The curative effect in the test group is much better than that in the control group (P<0.05). Conclusion: The application of Ahylysantinfarctase has provided an effective method for treating cor pulmonale.
Keywords:Ahylysantinfarctase  Cor pulmonale  Treatment
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号